Lakewood-Amedex is registering an additional 4,512,400 shares of common stock for resale by a selling stockholder. This increase in registrable shares is due to the unadjusted floor price of the Series C Preferred Stock following a 1-for-10 reverse stock split, effectively increasing the number of common shares issuable upon conversion.
Lakewood-Amedex is filing to register an additional 4,512,400 shares of common stock for resale by a selling stockholder. This significant increase in registrable shares stems from a technicality related to the company's recent 1-for-10 reverse stock split: the $1.00 floor price for Series C Preferred Stock conversion was not adjusted, leading to more common shares being issuable upon conversion. This event is negative for existing shareholders as it signals potential future dilution, as the selling stockholder can now convert and sell a substantially larger number of shares. While the company itself receives no proceeds from these sales, the increased supply of shares on the market could exert downward pressure on the stock price in the short to medium term, affecting retail and institutional investors holding LAKE shares.